Suchergebnisse - "Clarke, Robert B"

PubPharm (248)

1

International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer : European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations

enthalten in: The Lancet. Oncology | 2024

von Meattini, I. | Becherini, C. | Caini, S. | +39

2

Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Li, S. | Hammarlund, J. | Wu, G. | +8

CommentIn: Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2401496121. - PMID 38422063

3

Proteomics of Patient-derived Breast Tumours Identifies a Pro-migratory Osteomodulin-Cyclin Dependent Kinase 1 Axis which Drives Bone Metastasis

enthalten in: bioRxiv.org | 2023

von Parsons, J. | Harrison, H. | Kedward, T. | +12

4

Imagine beyond : recent breakthroughs and next challenges in mammary gland biology and breast cancer research

enthalten in: Journal of mammary gland biology and neoplasia | 2023

von van Amerongen, R. | Bentires-Alj, M. | van Boxtel, A. | +10

5

Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research

enthalten in: Journal of mammary gland biology and neoplasia | 2023

von van Amerongen, R. | Bentires-Alj, M. | van Boxtel, A. | +10

6

Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research

enthalten in: Journal of mammary gland biology and neoplasia | 2023

von van Amerongen, R. | Bentires-Alj, M. | van Boxtel, A. | +10

7

RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells

enthalten in: Oncogene | 2023

von Chen, F. | Gurler, S. | Novo, D. | +15

8

Author Correction : High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

enthalten in: Nature communications | 2022

von Palafox, M. | Monserrat, L. | Bellet, M. | +35

ErratumFor: Nat Commun. 2022 Sep 7;13(1):5258. - PMID 36071033

9

Targeting STAT3 signalling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer

enthalten in: bioRxiv.org | 2022

von Simões, B. | Santiago-Gómez, A. | Chiodo, C. | +15

10

High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

enthalten in: Nature communications | 2022

von Palafox, M. | Monserrat, L. | Bellet, M. | +35

ErratumIn: Nat Commun. 2022 Nov 14;13(1):6928. - PMID 36376284

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[25]